Kamal Adawi sold $14K of Fate Therapeutics stock

By AlphaYouPublished Nov 4, 2026Form 4

Stocks in this disclosure

Reported activity

Adawi Kamal

Reporting filer

Kamal Adawi reported selling 6,582 shares of Fate Therapeutics Inc for about $14K ($2.05 a share on average). Form 4 filed Nov 4, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Adawi Kamal	2026-11-03	S	Sale	6582	2.0548	93,418	1 day	Filed terms security Title: Common Stock transaction Date: 2026-11-03 transaction Form Type: 4 transaction Code: S equity Swap Involved: false id: F1 transaction Shares: 6582 transaction Price Per Share: 2.0548 id: F2 transaction Acquired Disposed Code: D shares Owned Following Transaction: 93418 direct Or Indirect Ownership: D

Owner: Adawi Kamal
Date: 2026-11-03
Code: S
Action: Sale
Quantity: 6582
Price: 2.0548
Following holdings: 93,418
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-11-03
transaction Form Type: 4
transaction Code: S
equity Swap Involved: false
id: F1
transaction Shares: 6582
transaction Price Per Share: 2.0548
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 93418
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Adawi Kamal: Chief Financial Officer.
F1: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 18,750 shares of Common Stock underlying RSUs granted to the Reporting Person on October 20, 2025. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through "sell-to-cover" transactions and were not made at the discretion of the Reporting Person.
F2: Represents the weighted average sale price of the shares sold ranging from $2.020 to $2.084 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

Prepared automatically from public filing data. Report a correction.